Fumiko Kimura MD, PhD, Presenter: Stockholder, JMS Co, Ltd Reseach Grant, DAIICHI SANKYO Group Reseach Grant, Bayer AG Reseach Grant, Eisai Co, Ltd

Takatomo Nakajima MD, Abstract Co-Author: Nothing to Disclose

Masahiro Takahashi MD, Abstract Co-Author: Nothing to Disclose

Toshiko Hoshi MD, Abstract Co-Author: Nothing to Disclose

Shintaro Nakano MD, Abstract Co-Author: Nothing to Disclose

Shigetoshi Nishimura MD, PhD, Abstract Co-Author: Nothing to Disclose

Fumikazu Sakai MD, PhD, Abstract Co-Author: Research Consultant, Bayer AG Research Consultant, F. Hoffman-La Roche Ltd Research Consultant, Takeda Pharmaceutical Company Limited Research Consultant, AstraZeneca PLC Research Consultant, Merck KGaA Research Consultant, Johnson & Johnson Research Consultant, Merck & Co, Inc Research Consultant, Kyowa-Kirin Co, Ltd Research Consultant, Bristol-Myers Squibb Company Research Consultant, Pfizer Inc Speaker, DAIICHI SANKYO Group Speaker, Eisai Co, Ltd Speaker, KYORIN Holdings, Inc Speaker, Shionogi & Co, Ltd Speaker, Dainippon Sumitomo Pharma Co, Ltd Research Grant, Bayer AG Research Grant, Eisai Co, Ltd Research Grant, LTT Bio-Pharma Co, Ltd

Recently, cardiac magnetic resonance (CMR) is frequently performed for patients who present with heart failure without coronary artery disease because it is mandatory to identify the underlying etiology of the heart failure. The purpose of this exhibit is 1. To review CMR imaging and underlying pathophysiological findings in patients with heart failure and without coronary artery stenosis 2. To learn how to identify etiology underlying heart failure using our decision charts with CMR 3. To learn characteristic CMR findings that should not be missed to reach diagnosis

1. Imaging techniques of T2-weighted images and late gadolinium enhancement (LGE) 2. Pitfalls of T2-weighted images and LGE 3. Review of imaging findings in primary and secondary cardiomyopathies, including dilated cardiomyopathy, hypertrophic cardiomyopathy, myocarditis, Takotsubo cardiomyopathy, hypertensive heart disease, Loeffler’s endocarditis, cardiac sarcoidosis, amyloidosis, and drug-induced cardiomyopathy. 4. Decision tree using CMR findings 5. Differential diagnosis using LGE pattern

http://abstract.rsna.org/uploads/2014/14012955/14012955_obu9.pdf

Kimura, F, Nakajima, T, Takahashi, M, Hoshi, T, Nakano, S, Nishimura, S, Sakai, F, How to Diagnose Patients Who Present with Heart Failure without Coronary Artery Stenosis: Using Cardiac MRI —  Minimum Essentials for Radiologists.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14012955.html